Resmed Inc. buy JPMorgan Chase & Co.
Start price
09.10.23
/
50%
€138.70
Target price
09.10.24
-
Performance (%)
56.31%
End price
10.10.24
€216.80
Summary
This prediction ended on 10.10.24 with a price of €216.80. The BUY prediction by JPMorgan_Chase___Co_ for Resmed Inc. saw massive gains of 56.31%. JPMorgan_Chase___Co_ has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.82 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -1.365% | -1.365% | -2.430% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten